Why the study?
What are the outcomes and potential role of Thoracic Endovascular Aortic Repair (TEVAR) in patients with Marfan syndrome requiring secondary interventions on the descending thoracic aorta?
What are the outcomes and potential role of Thoracic Endovascular Aortic Repair (TEVAR) in patients with Marfan syndrome requiring secondary interventions on the descending thoracic aorta?
This review assesses the potential role and outcomes of Thoracic Endovascular Aortic Repair (TEVAR) for aortic dissection in patients with Marfan syndrome.
TEVAR may warrant consideration in select Marfan cases; leaves open need for prospective trials before broader adoption.
Over the last decades, improvement of medical and surgical therapy has increased life expectancy in Marfan patients. Consequently, the number of such patients requiring secondary interventions on the descending thoracic aorta due to new or residual dissections, and distal aneurysm formation has substantially enlarged. Surgical and endovascular procedures represent two valuable options of treatment, both associated with advantages and drawbacks. The aim of the present manuscript was to review endovascular outcomes in Marfan syndrome and to assess the potential role of Thoracic Endovascular Aortic Repair (TEVAR) in this subset of patients.
No takes yet. Share an insight, caveat, or question.
Parisi et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: